Merrimack Pharmaceuticals, Inc.
(NASDAQ : MACK)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen, Inc.
1.13%302.781.4%$587.61m
AMGNAmgen, Inc.
0.21%233.901.3%$519.01m
GILDGilead Sciences, Inc.
1.87%67.161.0%$370.38m
REGNRegeneron Pharmaceuticals, Inc.
1.03%372.122.6%$303.57m
VRTXVertex Pharmaceuticals, Inc.
-0.02%223.021.9%$268.06m
ILMNIllumina, Inc.
2.26%327.053.5%$238.37m
ARWRArrowhead Pharmaceuticals, Inc.
2.92%67.4412.0%$192.67m
EXASEXACT Sciences Corp.
3.56%86.5924.0%$184.80m
CLVSClovis Oncology, Inc.
11.29%9.8614.7%$180.42m
ALXNAlexion Pharmaceuticals, Inc.
5.51%113.342.0%$179.50m
SRPTSarepta Therapeutics, Inc.
-0.29%109.6514.6%$148.41m
AAgilent Technologies, Inc.
0.68%82.081.6%$141.44m
BMRNBioMarin Pharmaceutical, Inc.
0.75%80.684.3%$131.07m
SGENSeattle Genetics, Inc.
0.43%117.666.1%$128.43m
NBIXNeurocrine Biosciences, Inc.
-0.43%115.985.0%$127.01m

Company Profile

Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA.